£111.99

Academic Press NK Cells in Cancer Immunotherapy: Successes and Challenges (Volume 4) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 4)

Price data checked 2 days ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£112 today · previous high £112 · all-time low £15

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 89 days • 89 data points

Historical
Generating forecast...
£111.99 £5.15 £28.46 £51.77 £75.08 £98.39 £121.70 18 February 2026 12 March 2026 03 April 2026 25 April 2026 17 May 2026

Price Distribution

Price distribution over 89 days • 4 price ranges

Days at Price
Current Price
44 days 28 days 14 days 3 days · current 0 11 22 33 44 £15-34 £34-54 £73-93 £93-112 Days at Price

Price Analysis

Most common range: £15-34 (44 days, 49.4%)

Price range: £15 - £112

Price levels: 4 price ranges over 89 days

Description

NK Cells in Cancer Immunotherapy: Successes and Challenges explains the latest immunotherapeutic strategies, focusing on NK cells to allow the best and precise combination treatments to cancer patients. The book provides existing background knowledge in the field of immunotherapy and discusses future areas of research required to carry out cutting-edge, validated therapies. Chapters cover advances in immunotherapeutic strategies, in particular, the use of NK cells with and without T-cell therapy in the treatment of cancer. The book is a valuable resource for cancer researchers, oncologists, graduate students and those interested in learning more about novel strategies to treat cancer patients. Immunotherapy is fast becoming the method of choice for cancer therapy. Although remarkable advances have been made in the field of immunotherapy, there are significant challenges and difficulties ahead since many of the current immunotherapeutic strategies do not provide long-lasting treatment strategies, and therefore are not very effective. Covers CAR/T and CAR/NK and adoptive NK cell therapy with and without T cell therapies Discusses basic biology of NK cells and mouse models of human cancers and the role of NK cells in metastatic cancer and in cancer stem cells Encompasses information on combination therapies using check point inhibition, adoptive transfer of cytotoxic effector cells, chemotherapeutic drugs and activating and inhibitory antibodies

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
13 December 2022
Listed Since
03 January 2020

Barcode

No barcode data available

Similar Products You Might Like

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
85% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£111.48 18 May 2026
Natural Killer Cells: At the Forefront of Modern Immunology
83% match

Natural Killer Cells: At the Forefront of Modern Immunology

Springer

£107.98 18 May 2026
Cancer Immunotherapy: Paradigms, Practice and Promise
83% match

Cancer Immunotherapy: Paradigms, Practice and Promise

Springer

£108.92 18 May 2026
Experimental and Applied Immunotherapy
82% match

Experimental and Applied Immunotherapy

Humana

£140.31 04 May 2026
Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)
82% match

Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)

Humana

£103.24 18 May 2026
Cellular Therapies for Cancer Treatment: Advancements in Drug Delivery Strategies
82% match

Cellular Therapies for Cancer Treatment: Advancements in Drug Delivery Strategies

Academic Press

£141.99 11 May 2026
Natural Killer T cells: Balancing the Regulation of Tumor Immunity (Cancer Drug Discovery and Development)
82% match

Natural Killer T cells: Balancing the Regulation of Tumor Immunity (Cancer Drug Discovery and Development)

Humana

£75.68 18 May 2026
General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology
81% match

General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology

Springer

£147.83 11 May 2026
Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)
81% match

Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)

Humana

£107.98 18 May 2026
Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms and Therapy: 1248 (Advances in Experimental Medicine and Biology, 1248)
80% match

Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms and Therapy: 1248 (Advances in Experimental Medicine and Biology, 1248)

Springer

£142.76 19 May 2026
Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy
80% match

Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy

Academic Press

£157.99 11 May 2026
80% match

Theranostic Approaches in Nuclear Medicine as a Strategy to Overcome Cancer Treatment Resistance (Novel approaches to overcome cancer resistance to conventional therapies)

Academic Press

£137.99 18 May 2026
Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)
80% match

Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)

Springer

£107.66 18 May 2026
Pharmacology of Immunotherapeutic Drugs
80% match

Pharmacology of Immunotherapeutic Drugs

Springer

£74.05 18 May 2026
79% match

Molecular Mechanisms of Cancer Resistance: Emerging Technologies and Therapeutic Strategies (Novel approaches to overcome cancer resistance to conventional therapies)

Academic Press

£153.99 11 May 2026
Nano-Oncologicals: New Targeting and Delivery Approaches (Advances in Delivery Science and Technology)
79% match

Nano-Oncologicals: New Targeting and Delivery Approaches (Advances in Delivery Science and Technology)

Springer

£114.71 11 May 2026
Cancer Gene Therapy by Viral and Non-viral Vectors: 4 (Translational Oncology)
79% match

Cancer Gene Therapy by Viral and Non-viral Vectors: 4 (Translational Oncology)

Wiley

£105.71 04 May 2026
Nutraceuticals and Cancer
79% match

Nutraceuticals and Cancer

Springer

£113.76 18 May 2026
Immune Metabolism in Health and Tumor: 1011 (Advances in Experimental Medicine and Biology, 1011)
79% match

Immune Metabolism in Health and Tumor: 1011 (Advances in Experimental Medicine and Biology, 1011)

Springer

£87.29 18 May 2026
79% match

Pharmacology of T-Cell Therapies (Volume 106) (Advances in Pharmacology, Volume 106)

Academic Press

£177.00 10 May 2026
Stem Cells and Cancer
79% match

Stem Cells and Cancer

Springer

£107.98 18 May 2026
79% match

Nanotechnology in Brain Tumor Treatment: Unveiling Molecular Mechanisms and Pioneering Therapies

Academic Press

£137.99 11 May 2026
Targeted Radionuclide Tumor Therapy: Biological Aspects
79% match

Targeted Radionuclide Tumor Therapy: Biological Aspects

Springer

£123.38 11 May 2026
79% match

Immunotherapies for Neurological Disorders: Unlocking the Brain's Defenses

Academic Press

£137.99 11 May 2026